United Kingdom Omega 3 Supplements Market Size & Outlook, 2025-2033
United Kingdom Omega 3 Supplements Market Insights
- According to Deep Market Insights analysis, the United Kingdom Omega 3 Supplements Market size was USD 496.22 Million in 2024 and is projected to reach USD 1065.97 Million by 2033.
- The United Kingdom market is projected to grow at a CAGR of 8.83% between 2026 and 2033.
- By segment, Fish Oil emerged as the largest Source in terms of market size in 2024.
- Plant Based Oil is anticipated to remain the most attractive Source segment, recording the fastest growth during the forecast period.
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- In 2024, United Kingdom accounted for 6.28% of the global Omega 3 Supplements Market size.
- By 2033, United States is expected to lead the global Omega 3 Supplements Market in terms of market size.
- Within Europe, Germany is projected to dominate the regional Omega 3 Supplements Market size by 2033.
- Benelux is identified as the fastest-growing market in Europe, anticipated to reach USD 250.64 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 496.22 Million |
| Market Size In 2033 | USD 1065.97 Million |
| Largest segment | Fish Oil |
| Units | Revenue in USD Million |
| CAGR | 8.83% (2025-2033) |
| Segmnetation Covered | |
| Source |
|
| Form |
|
| End User |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United Kingdom Omega 3 Supplements Market Source 2025-2033 (USD Million)
| Source | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fish Oil | XX.x | XX.x | XX.x | 241.56 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Krill Oil | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Algal Oil | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Plant Based Oil | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United Kingdom Omega 3 Supplements Market Form 2025-2033 (USD Million)
| Form | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Softgels | XX.x | XX.x | XX.x | 209.76 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Capsules | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Liquid | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Gummies | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Powder | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United Kingdom Omega 3 Supplements Market End User 2025-2033 (USD Million)
| End User | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adults | XX.x | XX.x | XX.x | 199.48 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Children | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Pregnant Women | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Older Adults | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.